FibroGen, Inc. (FGEN)
8.63
+0.12
(+1.47%)
USD |
NASDAQ |
Dec 10, 13:18
FibroGen Profit Margin (Quarterly): -1.22K% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Assertio Holdings, Inc. | 23.14% |
| Perspective Therapeutics, Inc. | -12.43K% |
| Skye Bioscience, Inc. | -- |
| Theravance Biopharma, Inc. | 18.08% |
| Myomo, Inc. | -36.30% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -27.24% |
| Gross Profit Margin (Quarterly) | 87.55% |
| Operating Margin (Quarterly) | -499.1% |
| Return on Net Operating Assets | -204.4% |